NeoStem Signs China Stem Cell Deal with Enhance BioMedical

NeoStem, Inc., a company built on collection and storage of adult stem cells, signed an exclusive 10-year agreement with Enhance BioMedical Holdings Limited of Shanghai. Using NeoStem developed techniques, Enhance will build a stem cell collection and treatment network. The facilities are targeted for Shanghai, Taiwan, and the provinces of Jiangsu, Zhejiang, Fujian, Anhui and Jiangxi. More details... Stock Symbol: (NYSE Amex: NBS)